Droperidol and Zide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Droperidol (droperidol) and Zide (hydrochlorothiazide). Common drug interactions include cardiomegaly among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Droperidol and Zide. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,452 Droperidol users. Check the latest studies of Droperidol.

What is Zide?

Zide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 183,246 Zide users. Check the latest studies of Zide.



On Jul, 31, 2026

44 people who take Droperidol and Zide together, and have interactions are studied.

Droperidol and Zide drug interactions.

What are the common drug interactions of Droperidol and Zide, by gender? *:

female:

  1. Cardiomegaly (increased size of heart than normal)
  2. Pleural effusion (water on the lungs)
  3. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  4. Angiopathy (generic term for a disease of the blood vessels)
  5. Anxiety
  6. Asthenia (weakness)
  7. Breast tenderness
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Conjunctivitis (pink eye)
  10. Constipation

male:

  1. Pain
  2. Anxiety
  3. Urethral obstruction (blockage of the urethra causing difficulty with urination)
  4. Urethral stenosis (narrowing of the urethra, may cause decreased urine output)
  5. Urinary retention (the inability to completely or partially empty the bladder)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Conjunctivitis (pink eye)
  8. Death
  9. Dyspnoea (difficult or laboured respiration)
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the common drug interactions of Droperidol and Zide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Tardive dyskinesia (a disorder that involves involuntary movements)
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Cough
  5. Cytomegalovirus infection
  6. Dyspnoea (difficult or laboured respiration)
  7. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  8. Forced expiratory volume decreased (decreased lung expired air volume)
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Neuropathy peripheral (surface nerve damage)

50-59:

  1. Arthralgia (joint pain)
  2. Aspartate aminotransferase increased
  3. Atelectasis (partial or complete collapse of the lung)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Blood albumin decreased
  6. Blood bicarbonate decreased
  7. Blood calcium decreased
  8. Blood magnesium decreased
  9. Blood phosphorus increased
  10. Blood triglycerides increased

60+:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Pain
  3. Asthenia (weakness)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Breast tenderness
  6. Cardiomegaly (increased size of heart than normal)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Conjunctivitis (pink eye)
  9. Constipation
  10. Cyst (a closed sac)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 11 people, 25.00%
  2. Headache (pain in head): 10 people, 22.73%
  3. Fever: 10 people, 22.73%
  4. Anaesthesia: 8 people, 18.18%
  5. Metastases To Bone (cancer spreads to bone): 6 people, 13.64%
  6. Pain: 4 people, 9.09%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.09%
  8. Nausea (feeling of having an urge to vomit): 3 people, 6.82%
  9. High Blood Cholesterol: 3 people, 6.82%
  10. Dementia With Lewy Bodies (progressive degenerative disease or syndrome of the brain): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Droperidol and Zide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Droperidol and Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Droperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on droperidol and hydrochlorothiazide (the active ingredients of Droperidol and Zide, respectively), and Droperidol and Zide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: